Open AccessImmunogenicity After a Heterologous BNT262b2 Versus Homologous Booster in Kidney Transplant Recipients Receiving 2 Doses of CoronaVac Vaccine: A Prospective Cohort Study
Author(s) -
José Osmar MedinaPestana,
Laila Almeida Viana,
Mônica Rika Nakamura,
Elizabeth França Lucena,
Celso Francisco Hernandes Granato,
Yasmim Cardoso Dreige,
Laysla Verhalen Pouzo Amorim,
Charles Yea Zen Chow,
Renato Demarchi Foresto,
Lúcio R. Requião-Moura,
Hélio TedescoSilva,
Marina Pontello Cristelli
Publication year - 2022
Publication title -
transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.45
H-Index - 204
eISSN - 1534-6080
pISSN - 0041-1337
DOI - 10.1097/tp.0000000000004260
Subject(s) - medicine , heterologous , seroprevalence , immunogenicity , seroconversion , immunology , neutralizing antibody , titer , antibody , booster dose , serology , biology , biochemistry , gene